Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebicapone PK and Motor Response in PD
NCT02834507Phase 2Completed
- Sponsor
- BIAL
- Start
- Mar 2005
- Primary completion
- Nov 2005
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of nebicapone in Parkinson's disease (PD) (4 arms), sponsored by BIAL. Primary endpoints: Maximum plasma concentrations, Time to Cmax and 2 more. Started Mar 2005; status: completed.
02
Drugs
nebicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02834507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02834507.